Neonatal Loss Secondary to Third Trimester Chemotherapy for Maternal Breast Cancer
Breast cancer is the most common cancer among women with a lifetime risk of 11%. Pregnancy-associated breast cancer is defined as cancer diagnosed during pregnancy or up to 1 year post partum. Surgery is the definitive treatment for pregnancy-associated breast cancer. For node-positive patients or n...
Main Authors: | Özgür Özyüncü, Işın Üreyen, Sadettin Kılıçkap, Yusuf Alper Kılıç, Sezcan Mümüşoğlu, Sinan Beksaç |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Network
2010-04-01
|
Series: | Gynecology Obstetrics & Reproductive Medicine |
Subjects: | |
Online Access: | http://gorm.com.tr/index.php/GORM/article/view/338 |
Similar Items
-
Limb Body Wall Complex: First Trimester Ultrasonographic Diagnosis of a Case with Exencephaly and Megacystis
by: Mert Turğal, et al.
Published: (2016-02-01) -
Third trimester maternal 1,25-dihydroxyvitamin D and neonatal birth weight
by: Yusrawati Yusrawati, et al.
Published: (2017-04-01) -
Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis
by: Song Y, et al.
Published: (2018-12-01) -
Correlation between the third trimester maternal anxiety and neonatal pain during invasive procedures
by: Shilan Azizi, et al.
Published: (2015-10-01) -
Pregnancy Outcome of Renal Transplant Recipients: Analysis of Nine Patients
by: Mert Turğal, et al.
Published: (2016-05-01)